Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction

International Journal of Cardiovascular Imaging

Volumn 25, Issue 5, 2009, Pages 519-527

  Larose, Eric ^a   Cǒté, Julie ^a   Rodés Cabau, Josep ^a   Noël, Bernard ^a   Barbeau, Gerald ^a   Bordeleau, Edith ^a   Miró, Santiago ^a   Brochu, Bernard ^a   Delarochellière, Robert ^a   Bertrand, Olivier F ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acute myocardial infarction; Contrast nephropathy; Magnetic resonance imaging; Primary coronary angioplasty; Safety

Indexed keywords

GADODIAMIDE; GADOLINIUM; IODINATED CONTRAST MEDIUM;

ADULT; ANGINA PECTORIS; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 67349221764     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-009-9451-4     Document Type: Article

References (38)

1. Yan AT, Shayne AJ, Brown KA et al (2006) Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114:32-39. doi: 10.1161/CIRCULATIONAHA.106.613414
2. Braunwald E (2003) Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. Circulation 108:III28-III37. doi: 10.1161/01.CIR.0000086952.14979.32
3. Thiele H, Kappl MJ, Linke A et al (2007) Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J 28:1433-1439. doi: 10.1093/eurheartj/ehm173
4. Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 110:e82-e292. doi: 10.1161/01.CIR.0000134791.68010.FA
5. Briguori C, Colombo A, Airoldi F et al (2006) Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 67:175-180. doi: 10.1002/ccd.20592
6. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259-2264. doi: 10.1161/ 01.CIR.0000016043.87291.33
7. Shellock FG (2002) Magnetic resonance safety update 2002: Implants and devices. J Magn Reson Imaging 16:485-496. doi: 10.1002/jmri.10196
8. Friedrich MG, Strohm O, Kivelitz D et al (1999) Behaviour of implantable coronary stents during magnetic resonance imaging. Int J Cardiovasc Intervent 2:217-222
9. Gerber TC, Fasseas P, Lennon RJ et al (2003) Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol 42:1295-1298. doi: 10.1016/S0735-1097(03)00993-8
10. Porto I, Selvanayagam J, Ashar V, Neubauer S, Banning AP (2005) Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol 96:366-368. doi: 10.1016/ j.amjcard.2005.03.077
11. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-1453. doi: 10.1056/NEJM200011163432003
12. Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215-223
13. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959-969. doi: 10.1016/ S0735-1097(00)00804-4
14. Ricciardi MJ, Davidson CJ, Gubernikoff G et al (2003) Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 145:522-528. doi: 10.1067/mhj.2003.2
15. Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 44:1393-1399
16. Liss P, Persson PB, Hansell P, Lagerqvist B (2006) Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 70:1811-1817. doi: 10.1038/ sj.ki.5001887
17. Thygesen K, Alpert JS, White HD et al (2007) Universal definition of myocardial infarction. Circulation 116:2634-2653. doi: 10.1161/ CIRCULATIONAHA.107.187397
18. Levey AS, Coresh J (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S266
19. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41. doi: 10.1159/000180580
20. De Luca G, Suryapranata H, Zijlstra F et al (2003) Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42:991-997. doi: 10.1016/S0735-1097(03)00919-7
21. Boden WE, Eagle K, Granger CB (2007) Reperfusion strategies in acute ST-segment elevation myocardial infarction: A comprehensive review of contemporary management options. J Am Coll Cardiol 50:917-929. doi: 10.1016/j.jacc.2007.04.084
22. Sadeghi HM, Stone GW, Grines CL et al (2003) Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108:2769-2775. doi: 10.1161/ 01.CIR.0000103623.63687.21
23. Abdel-Aty H, Zagrosek A, Schulz-Menger J et al (2004) Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109:2411-2416. doi: 10.1161/01.CIR.0000127428.10985.C6
24. Aletras AH, Tilak GS, Natanzon A et al (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113:1865-1870. doi: 10.1161/ CIRCULATIONAHA.105.576025
25. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
26. Kjoller E, Kober L, Jorgensen S, Torp-Pedersen C (1999) Long-term prognostic importance of hyperkinesia following acute myocardial infarction TRACE Study Group. Trandolapril cardiac evaluation. Am J Cardiol 83:655-659. doi: 10.1016/S0002-9149(98)00962-X
27. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE (2006) Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging 24:1056-1061. doi: 10.1002/jmri.20740
28. Patel MR, Albert TS, Kandzari DE et al (2006) Acute myocardial infarction: Safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology 240:674-680. doi: 10.1148/ radiol.2403050740
29. Bolick DR, Hackel DB, Reimer KA, Ideker RE (1986) Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation 74:1266-1279
30. de Bakker JM, Coronel R, Tasseron S et al (1990) Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: Role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol 15:1594-1607
31. Cury RC, Shash K, Nagurney JT et al (2008) Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 118:837-844. doi: 10.1161/CIRCULATIONAHA.107.740597
32. Shellock FG, Crues JV (2004) MR procedures: Biologic effects, safety, and patient care. Radiology 232:635-652. doi: 10.1148/radiol.2323030830
33. Shellock FG, Shellock VJ (1999) Metallic stents: Evaluation of MR imaging safety. Am J Roentgenol 173:543-547
34. Hug J, Nagel E, Bornstedt A, Schnackenburg B, Oswald H, Fleck E (2000) Coronary arterial stents: Safety and artifacts during MR imaging. Radiology 216:781-787
35. Bottomley PA, Redington RW, Edelstein WA, Schenck JF (1985) Estimating radiofrequency power deposition in body NMR imaging. Magn Reson Med 2:336-349. doi: 10.1002/mrm.1910020404
36. Krams R, Verheye S, van Damme LC et al (2005) In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity. Eur Heart J 26:2200-2205. doi: 10.1093/eurheartj/ehi461
37. Remy-Jardin M, Dequiedt P, Ertzbischoff O et al (2005) Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: Preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 235:819-826. doi: 10.1148/radiol.2353040734
38. Mitka M (2007) MRI contrast agents may pose risk for patients with kidney disease. JAMA 297:253-254. doi: 10.1001/jama.297.3.253